Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A newer revision label (v3.6.5) is shown, indicating a site update; the core study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-08-08T10:36:06.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The study record now lists UPMC Hillman Cancer Center as a participating site, replacing University of Pittsburgh Cancer Institute (UPCI). This reflects an organizational naming update and a new revision of the study record (v3.6.4).
    Difference
    0.2%
    Check dated 2026-08-01T09:28:50.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3. This signifies a new page version for maintenance or updates, without changing the substantive study information.
    Difference
    0.0%
    Check dated 2026-07-03T23:01:00.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a maintenance update to the page. This change does not alter the study details, eligibility criteria, or outcomes presented on the page.
    Difference
    0.0%
    Check dated 2026-06-26T23:47:36.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended (No longer looking for participants). New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was revised.
    Difference
    0.8%
    Check dated 2026-06-12T16:23:41.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing v3.5.4. This reflects a routine site update that does not alter the study details or page content.
    Difference
    0.0%
    Check dated 2026-06-05T11:50:54.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.